Anti-androgen shows benefit as adjuvant PCa therapy
Vienna, Austria--The first analysis of the Early Prostate Cancer program-presented3 years ago at the European Association of Urology annual congress-revealedthat the anti-androgen bicalutamide (Casodex), 150 mg, cuts prostate cancerprogression risk almost in half in patients with localized or locally advanceddisease. A second analysis, presented at this year's meeting, confirmedthat the earlier finding holds true whether patients are treated with radicalprostatectomy, radiotherapy, or watchful waiting.
Seeds vs. prostatectomy: Long- and short-term side effects differ slightly
March 15th 2007For men with prostate cancer, radiation seed implants may yield a better short-term side effect profile than surgery, but surgery may offer slightly better long-term outcomes, new research from French radiation oncologists indicates.
Brachytherapy offers high 8-year prostate Ca survival rates
February 15th 2007More than 90% of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of the disease 8 years after diagnosis, according to a recent study in the International Journal for Radiation Oncology Biology Physics (2007; 67:327-33).
Research on bladder tissue regeneration progresses
February 1st 2007Atlanta-Tissue engineering research has grown by leaps and bounds in the past decade and a half, yielding findings that may someday have a profound impact on the field of pediatric urology. At the 2006 American Academy of Pediatrics Section on Urology annual meeting here, several groups presented cutting-edge data on novel systems for organ generation, including research demonstrating the feasibility of generating a functioning bladder from stem cells.
Radiation therapy combination prolongs long-term cure rate in men with PCa
January 18th 2007Three-fourths of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study published in the International Journal of Radiation Oncology*Biology*Physics (2007; 67:57-64).
Cystectomy outcomes: Does surgeon's age matter?
October 1st 2006Ann Arbor, MI-Surgeon age is not a significant predictor of risk of mortality after cystectomy, according to the results of a recently published study from researchers at the University of Michigan, Ann Arbor (Ann Surg 2006; 244:353-62).
